DK1248608T3 - Diacerein til anvendelse i behandling af psoriasis - Google Patents

Diacerein til anvendelse i behandling af psoriasis

Info

Publication number
DK1248608T3
DK1248608T3 DK01900029T DK01900029T DK1248608T3 DK 1248608 T3 DK1248608 T3 DK 1248608T3 DK 01900029 T DK01900029 T DK 01900029T DK 01900029 T DK01900029 T DK 01900029T DK 1248608 T3 DK1248608 T3 DK 1248608T3
Authority
DK
Denmark
Prior art keywords
diacerein
psoriasis
treatment
Prior art date
Application number
DK01900029T
Other languages
English (en)
Inventor
Napoli Guido Di
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Application granted granted Critical
Publication of DK1248608T3 publication Critical patent/DK1248608T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01900029T 2000-01-12 2001-01-08 Diacerein til anvendelse i behandling af psoriasis DK1248608T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (1)

Publication Number Publication Date
DK1248608T3 true DK1248608T3 (da) 2004-04-05

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01900029T DK1248608T3 (da) 2000-01-12 2001-01-08 Diacerein til anvendelse i behandling af psoriasis

Country Status (22)

Country Link
US (2) US6844365B2 (da)
EP (1) EP1248608B1 (da)
JP (1) JP4912554B2 (da)
CN (1) CN1187045C (da)
AR (1) AR026801A1 (da)
AT (1) ATE254913T1 (da)
AU (1) AU776324B2 (da)
BR (2) BRPI0107493B8 (da)
CA (1) CA2396111C (da)
CZ (1) CZ301129B6 (da)
DE (1) DE60101309T2 (da)
DK (1) DK1248608T3 (da)
ES (1) ES2210120T3 (da)
IL (2) IL150390A0 (da)
MX (1) MXPA02006610A (da)
PL (1) PL212010B1 (da)
PT (1) PT1248608E (da)
RU (1) RU2266740C2 (da)
SK (1) SK286589B6 (da)
TR (1) TR200400228T4 (da)
WO (1) WO2001051044A2 (da)
ZA (1) ZA200205148B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
TWI399384B (zh) 2005-05-16 2013-06-21 Abbott Biotech Ltd ＴＮＦα抑制劑於治療侵蝕型多發性關節炎之用途
EP2666472A3 (en) * 2006-04-10 2014-04-02 Abbott Biotechnology Ltd Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
NZ602583A (en) * 2010-04-08 2014-10-31 Twi Biotechnology Inc Methods of using diacerein as an adjunctive therapy for diabetes
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
TWI794200B (zh) 2017-01-19 2023-03-01 安成生物科技股份有限公司 預防或治療免疫發炎性皮膚疾病的方法及醫藥組合物
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
KR20200138326A (ko) * 2018-03-29 2020-12-09 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 염증성 시토카인을 억제하기 위한 약제학적 조성물
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
BRPI0107493B8 (pt) 2021-05-25
WO2001051044A3 (en) 2002-03-28
US20020143057A1 (en) 2002-10-03
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
TR200400228T4 (tr) 2004-02-23
US6844365B2 (en) 2005-01-18
US20050004045A1 (en) 2005-01-06
AR026801A1 (es) 2003-02-26
WO2001051044A2 (en) 2001-07-19
CZ20022382A3 (cs) 2002-11-13
PL356784A1 (en) 2004-07-12
ZA200205148B (en) 2003-06-26
JP4912554B2 (ja) 2012-04-11
EP1248608A2 (en) 2002-10-16
CN1187045C (zh) 2005-02-02
CN1395484A (zh) 2003-02-05
DE60101309T2 (de) 2004-09-16
MXPA02006610A (es) 2004-09-10
AU776324B2 (en) 2004-09-02
SK9912002A3 (en) 2003-02-04
AU2213201A (en) 2001-07-24
BRPI0107493B1 (pt) 2019-04-16
PL212010B1 (pl) 2012-07-31
CZ301129B6 (cs) 2009-11-11
EP1248608B1 (en) 2003-11-26
ATE254913T1 (de) 2003-12-15
PT1248608E (pt) 2004-04-30
CA2396111A1 (en) 2001-07-19
CA2396111C (en) 2008-12-02
ES2210120T3 (es) 2004-07-01
JP2003519653A (ja) 2003-06-24
IL150390A (en) 2007-07-24
DE60101309D1 (de) 2004-01-08
BR0107493A (pt) 2002-10-08
IL150390A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
DK1248608T3 (da) Diacerein til anvendelse i behandling af psoriasis
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
EE200300043A (et) Mittesteroidsed põletikuvastased ained
DK1263503T3 (da) Anvendelse af cyanoquinoliner til behandling erller inhibering af tyktarmspolypper
DK1294644T3 (da) Vandbehandlingssammensætninger
NO20031869L (no) Antiinflammatoriske midler
ITMI20000630A0 (it) Impiego del resveratrolo per il trattamento di eczema disquamativo anche e psoriasi
DK1324970T3 (da) Retinoider til behandling af emfysem
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1176964T3 (da) Brug af ET743 til behandling af cancer
ID29506A (id) Masker sekali pakai
FR2810555B1 (fr) Catheter reutilisable
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
NO20024236L (no) Behandling av psoriasis
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
FR2805983B3 (fr) Douche
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
DK1296928T3 (da) Fremgangsmåde til oprensning af diacerein
NO20025765D0 (no) Kombinasjonssett for behandling av malaria
DK1363614T3 (da) Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens
FIU20010133U0 (fi) Jäteveden käsittelylaitteisto
DK1248638T3 (da) Anvendelse af enoxaparin til behandling af cerebral iskæmi